PAI-1 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "PAI-1" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

1,626^th place

2,018^th place

2ahajournals.org

3,608^th place

659^th place

low place

5,452^nd place

1ashpublications.org

low place

low place

1thieme-connect.com

low place

low place

1sciencedirect.com

149^th place

80^th place

ahajournals.org

ahajournals.org

Singh S, Kumar P, Padwad YS, Jaffer FA, Reed GL, Targeting fibrinolytic inhibition for venous thromboembolism treatment: Overview of an emerging therapeutic approach, Circulation, 2024;150!884-898

circ.ahajournals.org

Flevaris P, Khan SS, Eren M et al. Plasminogen Activator Inhibitor Type I controls cardiomyocyte Transforming Growth Factor-β and cardiac fibrosis, Circulation, 2017;136:664-679.

ashpublications.org

Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice, Blood, 2000;95:577–580

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000106366 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000037411 - Ensembl, May 2017

hogrefe.com

econtent.hogrefe.com

Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, Xu M, Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism: a meta-analysis and systematic review, VASA Zeitschrift fur Gefasskrankheiten, 2020;49:141–146

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
Elokdah H, Abou-Gharbia M, Hennan JK, McFarlane G, Mugford CP, Krishnamurthy G, Crandall DL. Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization. J Med Chem 2004;47:3491-4. PMID 15214776.

sciencedirect.com

Frischmuth T, Hindberg K, Aukrust P, Ueland T, Braekkan SK, Hansen JB, Morelli VM. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism, J Thromb Haemost, 2022;20:1618–1626

thieme-connect.com

Flevaris P, Vaughan D, The role of plasminogen activator inhibitor type-1 in fibrosis, Semin Thromb Hemost, 2017;43:169–177.